Medical
About Us

Investor Relations
In the clinical diagnostics industry, companies face a persistently challenging business environment due to ongoing medical cost control measures and rising raw material and transportation costs driven by geopolitical factors. To overcome this environment, we will pursue initiatives to become more cost-competitive and expand overseas with greater aggression and strategic intent. In Japan, the promotion of community-based integrated care systems has already begun in response to the diversifying medical and nursing care needs in an aging society. Overseas, continued growth is expected due to the need for efficiency in controlling medical costs and the expansion of preventive medicine in developed countries, as well as the development of medical infrastructure in conjunction with population growth and economic development in emerging countries.
Based on our management philosophy of “Protect the health of the public through health care services,” the Eiken Group will contribute to protecting the health of even more people through global expansion and aim for further growth.
Our Group has set forth "EIKEN Vision 2030" as its aspired vision for fiscal year 2030, incorporating a sustainability management perspective while remaining flexible in responding to changes in the business environment. By uniting management and employees in a spirit of speed and positivity, we strive to create innovation and achieve sustainable growth and steadily improved profitability.
We look forward to continued support and enthusiasm from all of our shareholders.
President & CEO
Yuji Segawa
![]()
Management
policy
Stock
Information